Vanqua Bio
Shivani Agarwal's work experience includes serving as a Senior Scientist at Vanqua Bio starting in April 2023. Prior to this, they worked as a Research Assistant Professor at Robert Lurie's Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University starting in July 2021. From January 2012 to January 2020, they held the roles of Postdoctoral Research Associate and Postdoctoral Associate at Northwestern University, Feinberg School of Medicine. Before joining Northwestern University, they worked as a Postdoctoral Researcher at Ohio State University, Department of Pathology from February 2010 to December 2011.
Shivani Agarwal began their education in 1999 at Delhi University where they pursued a Bachelor's Degree in Biochemistry. Shivani completed their undergraduate studies in 2002. Following that, from 2002 to 2004, they attended Delhi University again for their Master's Degree in Biochemistry. Finally, from 2005 to 2010, Shivani Agarwal enrolled at Jawaharlal Nehru Vishvavidyalaya, where they earned their Doctor of Philosophy (Ph.D.) in Biotechnology.
Vanqua Bio
Vanqua Bio is helping usher in a new era of hope for the millions of people living with neurodegenerative diseases. Our unique drug-development approach is designed to overcome longstanding challenges in the neuroscience field by capitalizing on the power of human genetics to identify genes that cause or increase the risk of neurodegenerative disease. We leverage novel, proprietary research tools and in vitro modeling of disease, based on patient-derived neuronal cells, to develop transformative therapies that slow or stop the progression of Parkinson’s disease (PD), Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and Gaucher disease (GD).